7-24702804-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_001127453.2(GSDME):c.1213G>A(p.Gly405Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001127453.2 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- autosomal dominant nonsyndromic hearing loss 5Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GSDME | NM_001127453.2 | c.1213G>A | p.Gly405Ser | missense_variant | Exon 9 of 10 | ENST00000645220.1 | NP_001120925.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Gly405Ser var iant in DFNA5 has not been previously reported in individuals with hearing loss and was absent from large population studies. The glycine (Gly) at position 405 is not conserved in mammals or evolutionary distant species, with two mammals ( elephant and manatee) having a serine (Ser) at this position, supporting that a change at this position may be tolerated. Additional computational prediction to ols suggest that the p.Gly405Ser variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. Pathogenic var iants in DFNA5 reported to date result in skipping of exon 8. This variant is no t predicted to impact splicing; however, functional studies are needed to comple tely rule out an impact to splicing. In summary, while the clinical significance of the p.Gly405Ser variant is uncertain, these data suggest that it is more lik ely to be benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at